Christine Mikail Cvijic, President and CFO at Neurogene Inc. (NGNE), sold 9,002 shares at $16.94 ($152K) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Scheduled sale ($152k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.94 | 4,501 | $76K | 50.0% |
| 2 | $16.94 | 4,501 | $76K | 50.0% |
| Total | $16.94 avg | 9,002 | $152K | 100% |
| Filing → |
| NGNE | SELL | 2026-05-08 | $300K | — | Filing → |
| NGNE | SELL | 2026-03-30 | $111K | — | Filing → |
| NGNE | SELL | 2026-03-17 | $168K | — | Filing → |